Original Research

Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: a meta-analysis of randomized controlled trials

Zhou JX, Feng LJ, Zhang X

Drug Design, Development and Therapy 2017, 11:3009-3017

Published Date: 13 October 2017